Who
Deborah H. Charych
Director
Company insider
Files Form 4 as: Director, Skye Bioscience.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 14 Feb 2023
- Last trade
- 31 Mar 2026
- Last filed
- 2 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 6 Feb 2026filed 9 Feb 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 6 Feb 2026filed 9 Feb 2026 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 28 Oct 2024filed 30 Oct 2024 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 29 Feb 2024filed 4 Mar 2024 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 6 Nov 2023filed 6 Nov 2023 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,110 at $0.00 | filing |
| 25 Aug 2023filed 29 Aug 2023 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,472,692 at $0.00 | filing |
| 14 Feb 2023filed 16 Feb 2023 | SKYE Skye Bioscienceoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.